Last reviewed · How we verify

NCT06095531

A Pilot Study to Evidence Improved Cranial Flap Fixation With a Bioresorbable Bone Adhesive

Active, enrolled NA Last updated 4 February 2026
What this trial tests

NA trial testing Tetranite for Cranial Flap Fixation (TN-CFF) in Craniotomy in 20 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
18 April 2024
Primary endpoint
8 December 2025
30 June 2026

Quick facts

Lead sponsorRevBio
PhaseNA
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment20
Start date18 April 2024
Primary completion8 December 2025
Estimated completion30 June 2026
Sites2 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

RevBio — full company profile →

Who can join

Adults 18 to 75, any sex, with Craniotomy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This clinical pilot study will evaluate the use of a bioresorbable bone adhesive to improve cranial flap fixation at two study time points (at the time of fixation and 6 months). The aim of this Pilot Study is to demonstrate the safety and efficacy of the use of Tetranite for Cranial Flap Fixation (TN-CFF) to allow clinical study of the TN-CFF device in a greater number of patients.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Demonstration of the safety of a regenerative bone adhesive for cranial flap fixation in a 12-week clinically relevant sheep model.
    Smith TR, Lazor JB, Slotkin JR, Woodard EJ, et al · · 2026 · PMID 41569731 · DOI 10.3171/2025.8.jns243158

Verify or expand the search:

Other trials of Tetranite for Cranial Flap Fixation (TN-CFF)

Trials testing the same drug.

Other recruiting trials for Craniotomy

Currently open trials in the same condition.

Other RevBio trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06095531.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing